Back to top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Image: Bigstock
Best Momentum Stock to Buy for December 5th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, December 5th:
PDD Holdings Inc. (PDD - Free Report) : This company which provides an e-commerce platform allowing users to participate in group buying deals, has a Zacks Rank #1(Strong Buy), and witnessed the Zacks Consensus Estimate for its current year earnings increasing 15.4% over the last 60 days.
PDD Holdings Inc. Price and Consensus
PDD Holdings Inc. price-consensus-chart | PDD Holdings Inc. Quote
PDD Holdings’ shares gained 41.3% over the last three month compared with the S&P 500’s gain of 2.2%. The company possesses a Momentum Score of A.
PDD Holdings Inc. Price
PDD Holdings Inc. price | PDD Holdings Inc. Quote
Harpoon Therapeutics : This company which is a clinical-stage immunotherapy company developing a novel class of T cell engagers which harness the power of the body's immune system to treat patients suffering from cancer and other diseases, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 66.9% over the last 60 days.
Harpoon Therapeutics, Inc. Price and Consensus
Harpoon Therapeutics, Inc. price-consensus-chart | Harpoon Therapeutics, Inc. Quote
Harpoon Therapeutics’ shares gained 20.5% over the last three month compared with the S&P 500’s gain of 2.2%. The company possesses a Momentum Score of A.
Harpoon Therapeutics, Inc. Price
Harpoon Therapeutics, Inc. price | Harpoon Therapeutics, Inc. Quote
Centrus Energy (LEU - Free Report) : This company which is a supplier of enriched uranium fuel for commercial nuclear power plants, has a Zacks Rank #1, and witnessed the Zacks Consensus Estimate for its current year earnings increasing 16.0% over the last 60 days.
Centrus Energy Corp. Price and Consensus
Centrus Energy Corp. price-consensus-chart | Centrus Energy Corp. Quote
Centrus Energy’s shares gained 59.2% over the last six month compared with the S&P 500’s gain of 7.4%. The company possesses a Momentum Score of B.
Centrus Energy Corp. Price
Centrus Energy Corp. price | Centrus Energy Corp. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.